23 Sep 2024 – We are thrilled to announce EyRIS’ strategic partnership with Al-Dawaa Medical Services Co., one of Saudi Arabia’s premier healthcare distributors. Together, we will bring our advanced AI solutions for retinal and chronic disease detection to the Kingdom, using just a simple fundus image.
As chronic conditions continue to rise despite ongoing public health efforts, there is a pressing need for innovative, accessible solutions. This collaboration will significantly enhance care delivery across the country, raising the bar for healthcare standards and improving patient outcomes.
Al-Dawaa Medical Services Co. extensive network and dedication to quality healthcare will enable us to extend the reach of our AI-driven technology, offering medical providers across Saudi Arabia access to EyRIS’ cutting-edge diagnostic tools. Our joint mission is to enable early detection and personalized care, ultimately reducing preventable blindness and improving quality of life.
We are excited about the transformative potential of this partnership and look forward to working closely with Al-Dawaa to reshape the future of healthcare in Saudi Arabia.
About EyRIS
EyRIS is at the forefront of healthcare innovation, 
leveraging AI to reshape first-line medical diagnostics. Our technology, capable of detecting retinal and chronic diseases through fundus imaging, is integrated into national screening programs across Ministries of Health in Asia and the Middle East, with a global presence in over 30
countries.
About Al-Dawaa Medical Services Co.
Founded in 1993, Al-Dawaa has grown into a leading healthcare 
provider in Saudi Arabia, operating over 900 pharmacies across 100+ cities. With a reputation for strategic growth and technology-driven solutions, Al-Dawaa continues to meet the evolving needs of the Saudi healthcare market.
For media inquiries, please contact enquiry@nova-hub.com
Comments are closed.